Neuroinflammation and Modulation Role of Natural Products After Spinal Cord Injury

References

• Quadri SA, Farooqui M, Ikram A, et al. Recent update on basic mechanisms of spinal cord injury. Neurosurg Rev. 2020;43:425–441. doi:10.1007/s10143-018-1008-3
   PubMed Web of Science ®Google Scholar
• Sun X, Jones ZB, Chen XM, et al. Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation. 2016;13:260. doi:10.1186/s12974-016-0736-y
   PubMed Web of Science ®Google Scholar
• Yong HYF, Rawji KS, Ghorbani S, et al. The benefits of neuroinflammation for the repair of the injured central nervous system. Cell Mol Immunol. 2019;16:540–546. doi:10.1038/s41423-019-0223-3
   PubMed Web of Science ®Google Scholar
• Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209:378–388. doi:10.1016/j.expneurol.2007.06.009
   PubMed Web of Science ®Google Scholar
• Jin X, Liu MY, Zhang DF, et al. Natural products as a potential modulator of microglial polarization in neurodegenerative diseases. Pharmacol Res. 2019;145:104253. doi:10.1016/j.phrs.2019.104253
   PubMed Web of Science ®Google Scholar
• Feng ST, Wang ZZ, Yuan YH, et al. Mangiferin: a multipotent natural product preventing neurodegeneration in Alzheimer’s and Parkinson’s disease models. Pharmacol Res. 2019;146:104336. doi:10.1016/j.phrs.2019.104336
   PubMed Web of Science ®Google Scholar
• Uchida Y, Yagi Y, Takao M, et al. Comparison of absolute protein abundances of transporters and receptors among blood-brain barriers at different cerebral regions and the blood-spinal cord barrier in humans and rats. Mol Pharm. 2020;17:2006–2020. doi:10.1021/acs.molpharmaceut.0c00178
   PubMedGoogle Scholar
• Jin LY, Li J, Wang KF, et al. Blood-spinal cord barrier in spinal cord injury: a review. J Neurotrauma. 2021;38:1203–1224. doi:10.1089/neu.2020.7413
   PubMedGoogle Scholar
• Maikos JT, Shreiber DI. Immediate damage to the blood-spinal cord barrier due to mechanical trauma. J Neurotrauma. 2007;24:492–507. doi:10.1089/neu.2006.0149
   PubMed Web of Science ®Google Scholar
• Figley SA, Khosravi R, Legasto JM, et al. Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. J Neurotrauma. 2014;31:541–552. doi:10.1089/neu.2013.3034
   PubMed Web of Science ®Google Scholar
• Yang Y, Estrada EY, Thompson JF, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27:697–709. doi:10.1038/sj.jcbfm.9600375
   PubMed Web of Science ®Google Scholar
• Hsu J-YC, McKeon R, Goussev S, et al. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci. 2006;26:9841–9850. doi:10.1523/JNEUROSCI.1993-06.2006
   PubMed Web of Science ®Google Scholar
• Lee JY, Choi HY, Ahn H-J, et al. Matrix metalloproteinase-3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury. Am J Pathol. 2014;184:2985–3000. doi:10.1016/j.ajpath.2014.07.016
   PubMed Web of Science ®Google Scholar
• Yu F, Kamada H, Niizuma K, et al. Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma. 2008;25:184–195. doi:10.1089/neu.2007.0438
   PubMed Web of Science ®Google Scholar
• Wells JEA, Rice TK, Nuttall RK, et al. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci. 2003;23:10107–10115. doi:10.1523/JNEUROSCI.23-31-10107.2003
   PubMed Web of Science ®Google Scholar
• Panahian N, Maines MD. Site of injury-directed induction of heme oxygenase-1 and −2 in experimental spinal cord injury: differential functions in neuronal defense mechanisms? J Neurochem. 2001;76:539–554. doi:10.1046/j.1471-4159.2001.00023.x
   PubMed Web of Science ®Google Scholar
• Lin Y, Vreman HJ, Wong RJ, et al. Heme oxygenase-1 stabilizes the blood-spinal cord barrier and limits oxidative stress and white matter damage in the acutely injured murine spinal cord. J Cereb Blood Flow Metab. 2007;27:1010–1021. doi:10.1038/sj.jcbfm.9600412
   PubMed Web of Science ®Google Scholar
• Liu Y, Tachibana T, Dai Y, et al. Heme oxygenase-1 expression after spinal cord injury: the induction in activated neutrophils. J Neurotrauma. 2002;19:479–490. doi:10.1089/08977150252932424
   PubMed Web of Science ®Google Scholar
• Lee T-S, Chau L-Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8:240–246. doi:10.1038/nm0302-240
   PubMed Web of Science ®Google Scholar
• Herrera JJ, Sundberg LM, Zentilin L, et al. Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury. J Neurotrauma. 2010;27:2067–2076. doi:10.1089/neu.2010.1403
   PubMed Web of Science ®Google Scholar
• Nourhaghighi N, Teichert-Kuliszewska K, Davis J, et al. Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab Invest. 2003;83:1211–1222. doi:10.1097/01.lab.0000082383.40635.fe
   PubMed Web of Science ®Google Scholar
• Han S, Arnold SA, Sithu SD, et al. Rescuing vasculature with intravenous angiopoietin-1 and alpha v beta 3 integrin peptide is protective after spinal cord injury. Brain. 2010;133:1026–1042. doi:10.1093/brain/awq034
   PubMed Web of Science ®Google Scholar
• Cabrera-Aldana EE, Ruelas F, Aranda C, et al. Methylprednisolone administration following spinal cord injury reduces aquaporin 4 expression and exacerbates edema. Mediators Inflamm. 2017;2017:4792932. doi:10.1155/2017/4792932
   PubMed Web of Science ®Google Scholar
• Kimura A, Hsu M, Seldin M, et al. Protective role of aquaporin-4 water channels after contusion spinal cord injury. Ann Neurol. 2010;67:794–801. doi:10.1002/ana.22023
   PubMed Web of Science ®Google Scholar
• Pan Y-L, Guo Y, Ma Y, et al. Aquaporin-4 expression dynamically varies after acute spinal cord injury-induced disruption of blood spinal cord barrier in rats. Neuropathology. 2019;39:181–186. doi:10.1111/neup.12539
   PubMed Web of Science ®Google Scholar
• Kitchen P, Salman MM, Halsey AM, et al. Targeting aquaporin-4 subcellular localization to treat central nervous system edema. Cell. 2020;181:784–799. doi:10.1016/j.cell.2020.03.037
   PubMed Web of Science ®Google Scholar
• Zeng C-W, Kamei Y, Shigenobu S, et al. Injury-induced Cavl-expressing cells at lesion rostral side play major roles in spinal cord regeneration. Open Biol. 2021;11:200304. doi:10.1098/rsob.200304
   PubMed Web of Science ®Google Scholar
• Shin T. Increases in the phosphorylated form of caveolin-1 in the spinal cord of rats with clip compression injury. Brain Res. 2007;1141:228–234. doi:10.1016/j.brainres.2007.01.009
   PubMed Web of Science ®Google Scholar
• Song L, Ge S, Pachter JS. Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood. 2007;109:1515–1523. doi:10.1182/blood-2006-07-034009
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Vaccari J, Dietrich WD, et al. Pattern recognition receptors and central nervous system repair. Exp Neurol. 2014;258:5–16. doi:10.1016/j.expneurol.2014.01.001
   PubMed Web of Science ®Google Scholar
• Amarante-Mendes GP, Adjemian S, Branco LM, et al. Pattern recognition receptors and the host cell death molecular machinery. Front Immunol. 2018;9:2379. doi:10.3389/fimmu.2018.02379
   PubMed Web of Science ®Google Scholar
• David BT, Ratnayake A, Amarante MA, et al. A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury. Neurobiol Dis. 2013;54:194–205. doi:10.1016/j.nbd.2012.12.012
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Lai W, Rivest S, et al. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem. 2007;102:37–50. doi:10.1111/j.1471-4159.2007.04524.x
   PubMed Web of Science ®Google Scholar
• Vaccari J, Minkiewicz J, Wang X, et al. Astrogliosis involves activation of retinoic acid-inducible gene-like signaling in the innate immune response after spinal cord injury. Glia. 2012;60:414–421. doi:10.1002/glia.22275
   PubMed Web of Science ®Google Scholar
• Orr MB, Gensel JC. Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics. 2018;15:541–553. doi:10.1007/s13311-018-0631-6
   PubMed Web of Science ®Google Scholar
• Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456–1458. doi:10.1126/science.1202529
   PubMed Web of Science ®Google Scholar
• Ueno M, Fujita Y, Tanaka T, et al. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci. 2013;16:543–551. doi:10.1038/nn.3358
   PubMed Web of Science ®Google Scholar
• Hagemeyer N, Hanft K-M, Akriditou M-A, et al. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol. 2017;134:441–458. doi:10.1007/s00401-017-1747-1
   PubMed Web of Science ®Google Scholar
• Hanke ML, Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci. 2011;121:367–387. doi:10.1042/CS20110164
   PubMed Web of Science ®Google Scholar
• Gaudet AD, Fonken LK. Glial cells shape pathology and repair after spinal cord injury. Neurotherapeutics. 2018;15:554–577. doi:10.1007/s13311-018-0630-7
   PubMed Web of Science ®Google Scholar
• Beck KD, Nguyen HX, Galvan MD, et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 2010;133:433–447. doi:10.1093/brain/awp322
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Gensel JC, Ankeny DP, et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435–13444. doi:10.1523/JNEUROSCI.3257-09.2009
   PubMed Web of Science ®Google Scholar
• Hu X, Leak RK, Shi Y, et al. Microglial and macrophage polarization-new prospects for brain repair. Nat Rev Neurol. 2015;11:56–64. doi:10.1038/nrneurol.2014.207
   PubMed Web of Science ®Google Scholar
• Gensel JC, Zhang B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 2015;1619:1–11. doi:10.1016/j.brainres.2014.12.045
   PubMed Web of Science ®Google Scholar
• Halassa MM, Fellin T, Takano H, et al. Synaptic islands defined by the territory of a single astrocyte. J Neurosci. 2007;27:6473–6477. doi:10.1523/JNEUROSCI.1419-07.2007
   PubMed Web of Science ®Google Scholar
• Gómez-Gonzalo M, Martin-Fernandez M, Martínez-Murillo R, et al. Neuron-astrocyte signaling is preserved in the aging brain. Glia. 2017;65:569–580. doi:10.1002/glia.23112
   PubMed Web of Science ®Google Scholar
• Stogsdill JA, Ramirez J, Liu D, et al. Astrocytic neuroligins control astrocyte morphogenesis and synaptogenesis. Nature. 2017;551:192–197. doi:10.1038/nature24638
   PubMed Web of Science ®Google Scholar
• Liebner S, Dijkhuizen RM, Reiss Y, et al. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135:311–336. doi:10.1007/s00401-018-1815-1
   PubMed Web of Science ®Google Scholar
• Attwell D, Buchan AM, Charpak S, et al. Glial and neuronal control of brain blood flow. Nature. 2010;468:232–243. doi:10.1038/nature09613
   PubMed Web of Science ®Google Scholar
• Bélanger M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14:724–738. doi:10.1016/j.cmet.2011.08.016
   PubMed Web of Science ®Google Scholar
• Jensen CJ, Massie A, Keyser JD. Immune players in the CNS: the astrocyte. J Neuroimmune Pharmacol. 2013;8:824–839. doi:10.1007/s11481-013-9480-6
   PubMed Web of Science ®Google Scholar
• Li L, Acioglu C, Heary RF, et al. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun. 2021;91:740–755. doi:10.1016/j.bbi.2020.10.007
   PubMed Web of Science ®Google Scholar
• Rivieccio MA, Suh H-S, Zhao Y, et al. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J Immunol. 2006;177:4735–4741. doi:10.4049/jimmunol.177.7.4735
   PubMed Web of Science ®Google Scholar
• Karimi-Abdolrezaee S, Billakanti R. Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol Neurobiol. 2012;46:251–264. doi:10.1007/s12035-012-8287-4
   PubMed Web of Science ®Google Scholar
• Almutairi MMA, Gong C, Xu YG, et al. Factors controlling permeability of the blood-brain barrier. Cell Mol Life Sci. 2016;73:57–77. doi:10.1007/s00018-015-2050-8
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012;33:579–589. doi:10.1016/j.it.2012.07.004
   PubMed Web of Science ®Google Scholar
• Gorina R, Font-Nieves M, Márquez-Kisinousky L, et al. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways. Glia. 2011;59:242–255. doi:10.1002/glia.21094
   PubMed Web of Science ®Google Scholar
• McKimmie CS, Graham GJ. Astrocytes modulate the chemokine network in a pathogen-specific manner. Biochem Biophys Res Commun. 2010;394:1006–1011. doi:10.1016/j.bbrc.2010.03.111
   PubMed Web of Science ®Google Scholar
• Pedrazzi M, Patrone M, Passalacqua M, et al. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J Immunol. 2007;179:8525–8532. doi:10.4049/jimmunol.179.12.8525
   PubMed Web of Science ®Google Scholar
• Moreno M, Guo F, Ko EM, et al. Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE. J Neurol Sci. 2013;333:55–59. doi:10.1016/j.jns.2012.12.014
   PubMed Web of Science ®Google Scholar
• Dong Y, Benveniste EN. Immune function of astrocytes. Glia. 2001;36:180–190. doi:10.1002/glia.1107
   PubMed Web of Science ®Google Scholar
• Rostami J, Fotaki G, Sirois J, et al. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain. J Neuroinflammation. 2020;17:119. doi:10.1186/s12974-020-01776-7
   PubMed Web of Science ®Google Scholar
• Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32:6391–6410. doi:10.1523/JNEUROSCI.6221-11.2012
   PubMed Web of Science ®Google Scholar
• Tarassishin L, Suh H-S, Lee SC. LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14. Glia. 2014;62:999–1013. doi:10.1002/glia.22657
   PubMed Web of Science ®Google Scholar
• Maupu C, Enderlin J, Igert A, et al. Diisopropylfluorophosphate-induced status epilepticus drives complex glial cell phenotypes in adult male mice. Neurobiol Dis. 2021;152:105276. doi:10.1016/j.nbd.2021.105276
   PubMed Web of Science ®Google Scholar
• Giovannoni F, Quintana FJ. The role of astrocytes in CNS inflammation. Trends Immunol. 2020;41:805–819. doi:10.1016/j.it.2020.07.007
   PubMed Web of Science ®Google Scholar
• Yan Y, Ding X, Li K, et al. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol Ther. 2012;20:1338–1348. doi:10.1038/mt.2012.12
   PubMed Web of Science ®Google Scholar
• Su Y, Chen Z, Du H, et al. Silencing miR-21 induces polarization of astrocytes to the A2 phenotype and improves the formation of synapses by targeting glypican 6 via the signal transducer and activator of transcription-3 pathway after acute ischemic spinal cord injury. FASEB J. 2019;33:10859–10871. doi:10.1096/fj.201900743R
   PubMed Web of Science ®Google Scholar
• Zhao N, Xu X, Jiang Y, et al. Lipocalin-2 may produce damaging effect after cerebral ischemia by inducing astrocytes classical activation. J Neuroinflammation. 2019;16:168. doi:10.1186/s12974-019-1556-7
   PubMed Web of Science ®Google Scholar
• Karababa A, Groos-Sahr K, Albrecht U, et al. Ammonia attenuates LPS-induced upregulation of pro-inflammatory cytokine mRNA in co-cultured astrocytes and microglia. Neurochem Res. 2017;42:737–749. doi:10.1007/s11064-016-2060-4
   PubMed Web of Science ®Google Scholar
• Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481–487. doi:10.1038/nature21029
   PubMed Web of Science ®Google Scholar
• Lepore AC, O’Donnell J, Kim AS, et al. Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury. Glia. 2011;59:1996–2005. doi:10.1002/glia.21241
   PubMed Web of Science ®Google Scholar
• Bezzi P, Domercq M, Brambilla L, et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci. 2001;4:702–710. doi:10.1038/89490
   PubMed Web of Science ®Google Scholar
• Norden DM, Fenn AM, Dugan A, et al. TGFβ produced by IL-10 redirected astrocytes attenuates microglial activation. Glia. 2014;62:881–895. doi:10.1002/glia.22647
   PubMed Web of Science ®Google Scholar
• Steelman AJ, Li J. Astrocyte galectin-9 potentiates microglial TNF secretion. J Neuroinflammation. 2014;11:144. doi:10.1186/s12974-014-0144-0
   PubMed Web of Science ®Google Scholar
• Peterson SL, Nguyen HX, Mendez OA, et al. Complement protein C3 suppresses axon growth and promotes neuron loss. Sci Rep. 2017;7:12904. doi:10.1038/s41598-017-11410-x
   PubMed Web of Science ®Google Scholar
• Lian H, Litvinchuk A, Chiang -AC-A, et al. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer’s disease. J Neurosci. 2016;36:577–589. doi:10.1523/JNEUROSCI.2117-15.2016
   PubMed Web of Science ®Google Scholar
• Hung -C-C, Lin C-H, Chang H, et al. Astrocytic GAP43 induced by the TLR4/NF-κB/STAT3 axis attenuates astrogliosis-mediated microglial activation and neurotoxicity. J Neurosci. 2016;36:2027–2043. doi:10.1523/JNEUROSCI.3457-15.2016
   PubMed Web of Science ®Google Scholar
• Acevedo G, Padala NK, Ni L, et al. Astrocytes inhibit microglial surface expression of dendritic cell-related co-stimulatory molecules through a contact-mediated process. J Neurochem. 2013;125:575–587. doi:10.1111/jnc.12221
   PubMed Web of Science ®Google Scholar
• Zhou R, Gao J, Xiang C, et al. Salvianolic acid A attenuated myocardial infarction-induced apoptosis and inflammation by activating Trx. Naunyn Schmiedebergs Arch Pharmacol. 2020;393:991–1002. doi:10.1007/s00210-019-01766-4
   PubMed Web of Science ®Google Scholar
• Liu C-D, Liu -N-N, Zhang S, et al. Salvianolic acid A prevented cerebrovascular endothelial injury caused by acute ischemic stroke through inhibiting the Src signaling pathway. Acta Pharmacol Sin. 2021;42:370–381. doi:10.1038/s41401-020-00568-2
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang R, Xu T, et al. Salvianolic acid A attenuates endoplasmic reticulum stress and protects against cholestasis-induced liver fibrosis via the SIRT1/HSF1 pathway. Front Pharmacol. 2018;9:1277. doi:10.3389/fphar.2018.01277
   PubMed Web of Science ®Google Scholar
• Zhou A-M, Xiang Y-J, Liu E-Q, et al. Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus. BMC Cardiovasc Disord. 2020;20:15. doi:10.1186/s12872-019-01316-z
   PubMed Web of Science ®Google Scholar
• Yu D-S, Wang Y-S, Bi Y-L, et al. Salvianolic acid A ameliorates the integrity of blood-spinal cord barrier via miR-101/Cul3/Nrf2/HO-1 signaling pathway. Brain Res. 2017;1657:279–287. doi:10.1016/j.brainres.2016.12.007
   PubMed Web of Science ®Google Scholar
• Wu Y, Xu S, Tian XY. The effect of salvianolic acid on vascular protection and possible mechanisms. Oxid Med Cell Longev. 2020;2020:5472096. doi:10.1155/2020/5472096
   PubMed Web of Science ®Google Scholar
• Li Z-M, Xu S-W, Liu P-Q. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin. 2018;39:802–824. doi:10.1038/aps.2017.193
   PubMed Web of Science ®Google Scholar
• Fan Z-K, Lv G, Wang Y-F, et al. The protective effect of salvianolic acid B on blood-spinal cord barrier after compression spinal cord injury in rats. J Mol Neurosci. 2013;51:986–993. doi:10.1007/s12031-013-0083-8
   PubMed Web of Science ®Google Scholar
• Fu J, Fan H-B, Guo Z, et al. Salvianolic acid B attenuates spinal cord ischemia-reperfusion-induced neuronal injury and oxidative stress by activating the extracellular signal-regulated kinase pathway in rats. J Surg Res. 2014;188:222–230. doi:10.1016/j.jss.2013.11.1118
   PubMed Web of Science ®Google Scholar
• Krzysztoforska K, Mirowska-Guzel D, Widy-Tyszkiewicz E. Pharmacological effects of protocatechuic acid and its therapeutic potential in neurodegenerative diseases: review on the basis of in vitro and in vivo studies in rodents and humans. Nutr Neurosci. 2019;22:72–82. doi:10.1080/1028415X.2017.1354543
   PubMed Web of Science ®Google Scholar
• Park CS, Lee JY, Choi HY, et al. Protocatechuic acid improves functional recovery after spinal cord injury by attenuating blood-spinal cord barrier disruption and hemorrhage in rats. Neurochem Int. 2019;124:181–192. doi:10.1016/j.neuint.2019.01.013
   PubMed Web of Science ®Google Scholar
• Hu J-Z, Huang J-H, Xiao Z-M, et al. Tetramethylpyrazine accelerates the function recovery of traumatic spinal cord in rat model by attenuating inflammation. J Neurol Sci. 2013;324:94–99. doi:10.1016/j.jns.2012.10.009
   PubMed Web of Science ®Google Scholar
• Wang C, Wang P, Zeng W, et al. Tetramethylpyrazine improves the recovery of spinal cord injury via Akt/Nrf2/HO-1 pathway. Bioorg Med Chem Lett. 2016;26:1287–1291. doi:10.1016/j.bmcl.2016.01.015
   PubMed Web of Science ®Google Scholar
• Fan L, Wang K, Shi Z, et al. Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury. J Vasc Surg. 2011;54:192–200. doi:10.1016/j.jvs.2010.12.030
   PubMed Web of Science ®Google Scholar
• Shin J-W, Moon J-Y, Seong J-W, et al. Effects of tetramethylpyrazine on microglia activation in spinal cord compression injury of mice. Am J Chin Med. 2013;41:1361–1376. doi:10.1142/S0192415X13500912
   PubMed Web of Science ®Google Scholar
• Zhang L, Lu X, Gong L, et al. Tetramethylpyrazine protects blood-spinal cord barrier integrity by modulating microglia polarization through activation of STAT3/SOCS3 and inhibition of NF-кB signaling pathways in experimental autoimmune encephalomyelitis mice. Cell Mol Neurobiol. 2021;41:717–731. doi:10.1007/s10571-020-00878-3
   PubMed Web of Science ®Google Scholar
• Du Q-H, Peng C, Zhang H. Polydatin: a review of pharmacology and pharmacokinetics. Pharm Biol. 2013;51:1347–1354. doi:10.3109/13880209.2013.792849
   PubMed Web of Science ®Google Scholar
• Lv R, Du L, Liu X, et al. Polydatin alleviates traumatic spinal cord injury by reducing microglial inflammation via regulation of iNOS and NLRP3 inflammasome pathway. Int Immunopharmacol. 2019;70:28–36. doi:10.1016/j.intimp.2019.02.006
   PubMed Web of Science ®Google Scholar
• Zhou Y-X, Gong X-H, Zhang H, et al. A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects. Biomed Pharmacother. 2020;130:110505. doi:10.1016/j.biopha.2020.110505
   PubMed Web of Science ®Google Scholar
• Wang B, Dai W, Shi L, et al. Neuroprotection by paeoniflorin against nuclear factor kappa B-induced neuroinflammation on spinal cord injury. Biomed Res Int. 2018;2018:9865403. doi:10.1155/2018/9865403
   PubMed Web of Science ®Google Scholar
• Liu P, Cheng J, Ma S, et al. Paeoniflorin attenuates chronic constriction injury‑induced neuropathic pain by suppressing spinal NLRP3 inflammasome activation. Inflammopharmacology. 2020;28:1495–1508. doi:10.1007/s10787-020-00737-z
   PubMed Web of Science ®Google Scholar
• Meeran MFN, Goyal SN, Suchal K, et al. Pharmacological properties, molecular mechanisms, and pharmaceutical development of asiatic acid: a pentacyclic triterpenoid of therapeutic promise. Front Pharmacol. 2018;9:892.
   PubMed Web of Science ®Google Scholar
• Gurcan O, Gurcay AG, Kazanci A, et al. Effect of asiatic acid on the treatment of spinal cord injury: an experimental study in rats. Turk Neurosurg. 2017;27:259–264. doi:10.5137/1019-5149.JTN.15747-15.2
   PubMed Web of Science ®Google Scholar
• Jiang W, Li M, He F, et al. Neuroprotective effect of asiatic acid against spinal cord injury in rats. Life Sci. 2016;157:45–51. doi:10.1016/j.lfs.2016.05.004
   PubMed Web of Science ®Google Scholar
• Rocha J, Eduardo-Figueira M, Barateiro A, et al. Anti-inflammatory effect of rosmarinic acid and an extract of Rosmarinus officinalis in rat models of local and systemic inflammation. Basic Clin Pharmacol Toxicol. 2015;116:398–413. doi:10.1111/bcpt.12335
   PubMed Web of Science ®Google Scholar
• Shang A-J, Yang Y, Wang H-Y, et al. Spinal cord injury effectively ameliorated by neuroprotective effects of rosmarinic acid. Nutr Neurosci. 2017;20:172–179. doi:10.1080/1028415X.2015.1103460
   PubMed Web of Science ®Google Scholar
• Ma Z, Lu Y, Yang F, et al. Rosmarinic acid exerts a neuroprotective effect on spinal cord injury by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-κB pathways. Toxicol Appl Pharmacol. 2020;397:115014. doi:10.1016/j.taap.2020.115014
   PubMed Web of Science ®Google Scholar
• Zhou Y-X, Zhang H, Peng C. Puerarin: a review of pharmacological effects. Phytother Res. 2014;28:961–975. doi:10.1002/ptr.5083
   PubMed Web of Science ®Google Scholar
• Zhang D, Ma G, Hou M, et al. The neuroprotective effect of puerarin in acute spinal cord injury rats. Cell Physiol Biochem. 2016;39:1152–1164. doi:10.1159/000447822
   PubMedGoogle Scholar
• Liu M, Liao K, Yu C, et al. Puerarin alleviates neuropathic pain by inhibiting neuroinflammation in spinal cord. Mediators Inflamm. 2014;2014:485927. doi:10.1155/2014/485927
   PubMed Web of Science ®Google Scholar
• Li N, Ou J, Bao N, et al. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition. Bioorg Chem. 2020;104:104208. doi:10.1016/j.bioorg.2020.104208
   PubMed Web of Science ®Google Scholar
• Zhang W, Cheng L, Hou Y, et al. Plumbagin protects against spinal cord injury-induced oxidative stress and inflammation in Wistar rats through Nrf-2 upregulation. Drug Res. 2015;65:495–499. doi:10.1055/s-0034-1389950
   PubMed Web of Science ®Google Scholar
• Yang W, Yang Y, Yang J-Y, et al. Treatment with bone marrow mesenchymal stem cells combined with plumbagin alleviates spinal cord injury by affecting oxidative stress, inflammation, apoptosis and the activation of the Nrf2 pathway. Int J Mol Med. 2016;37:1075–1082. doi:10.3892/ijmm.2016.2498
   PubMed Web of Science ®Google Scholar
• Wang S, Ren D. Allicin protects traumatic spinal cord injury through regulating the HSP70/Akt/iNOS pathway in mice. Mol Med Rep. 2016;14:3086–3092. doi:10.3892/mmr.2016.5651
   PubMed Web of Science ®Google Scholar
• Lv R, Mao N, Wu J, et al. Neuroprotective effect of allicin in a rat model of acute spinal cord injury. Life Sci. 2015;143:114–123. doi:10.1016/j.lfs.2015.11.001
   PubMed Web of Science ®Google Scholar
• Liu S-G, Ren P-Y, Wang G-Y, et al. Allicin protects spinal cord neurons from glutamate-induced oxidative stress through regulating the heat shock protein 70/inducible nitric oxide synthase pathway. Food Funct. 2015;6:321–330. doi:10.1039/c4fo00761a
   PubMed Web of Science ®Google Scholar
• Vincenzo AD, Tana C, Hadi HE, et al. Antioxidant, anti-Inflammatory, and metabolic properties of tocopherols and tocotrienols: clinical implications for vitamin E supplementation in diabetic kidney disease. Int J Mol Sci. 2019;20:5101. doi:10.3390/ijms20205101
   PubMed Web of Science ®Google Scholar
• Ghanem P, Zouein A, Mohamad M, et al. The vitamin E derivative gamma tocotrienol promotes anti-tumor effects in acute myeloid leukemia cell lines. Nutrients. 2019;11:2808. doi:10.3390/nu11112808
   PubMed Web of Science ®Google Scholar
• Frank J, Chin XWD, Schrader C, et al. Do tocotrienols have potential as neuroprotective dietary factors? Ageing Res Rev. 2012;11:163–180. doi:10.1016/j.arr.2011.06.006
   PubMed Web of Science ®Google Scholar
• Xun C, Mamat M, Guo H, et al. Tocotrienol alleviates inflammation and oxidative stress in a rat model of spinal cord injury via suppression of transforming growth factor-β. Exp Ther Med. 2017;14:431–438. doi:10.3892/etm.2017.4505
   PubMed Web of Science ®Google Scholar
• Ho Y, Lin Y-S, Liu H-L, et al. Biological mechanisms by which antiproliferative actions of resveratrol are minimized. Nutrients. 2017;9:1046. doi:10.3390/nu9101046
   PubMed Web of Science ®Google Scholar
• Xia N, Daiber A, Förstermann U, et al. Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol. 2017;174:1633–1646. doi:10.1111/bph.13492
   PubMed Web of Science ®Google Scholar
• Xu D, Li Y, Zhang B, et al. Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats. Int J Med Sci. 2016;13:942–954. doi:10.7150/ijms.16810
   PubMed Web of Science ®Google Scholar
• Liu C, Shi Z, Fan L, et al. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res. 2011;1374:100–109. doi:10.1016/j.brainres.2010.11.061
   PubMed Web of Science ®Google Scholar
• Fan R, Zhang Y, Botchway BOA, et al. Resveratrol can attenuate astrocyte activation to treat spinal cord injury by inhibiting inflammatory responses. Mol Neurobiol. 2021;19:1–15. doi:10.1007/s12035-021-02509-4
   Google Scholar
• Zhao H, Chen S, Gao K, et al. Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway. Neuroscience. 2017;348:241–254. doi:10.1016/j.neuroscience.2017.02.027
   PubMed Web of Science ®Google Scholar
• Xu L, Botchway BOA, Zhang S, et al. Inhibition of NF-κB signaling pathway by resveratrol improves spinal cord injury. Front Neurosci. 2018;12. doi:10.3389/fnins.2018.00690
   Web of Science ®Google Scholar
• Ge R, Zhu Y, Diao Y, et al. Anti-edema effect of epigallocatechin gallate on spinal cord injury in rats. Brain Res. 2013;1527:40–46. doi:10.1016/j.brainres.2013.06.009
   PubMed Web of Science ®Google Scholar
• Urdzikova LM, Ruzicka J, Karova K, et al. A green tea polyphenol epigallocatechin-3-gallate enhances neuroregeneration after spinal cord injury by altering levels of inflammatory cytokines. Neuropharmacology. 2017;126:213–223. doi:10.1016/j.neuropharm.2017.09.006
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang W, Wang L, et al. Curcumin prevents cerebral ischemia reperfusion injury via increase of mitochondrial biogenesis. Neurochem Res. 2014;39:1322–1331. doi:10.1007/s11064-014-1315-1
   PubMed Web of Science ®Google Scholar
• Samini F, Samarghandian S, Borji A, et al. Curcumin pretreatment attenuates brain lesion size and improves neurological function following traumatic brain injury in the rat. Pharmacol Biochem Behav. 2013;110:238–244. doi:10.1016/j.pbb.2013.07.019
   PubMed Web of Science ®Google Scholar
• Yu D-S, Cao Y, Mei X-F, et al. Curcumin improves the integrity of blood-spinal cord barrier after compressive spinal cord injury in rats. J Neurol Sci. 2014;346:51–59. doi:10.1016/j.jns.2014.07.056
   PubMed Web of Science ®Google Scholar
• Daverey A, Agrawal SK. Curcumin protects against white matter injury through NF-κB and Nrf2 cross talk. J Neurotrauma. 2020;37:1255–1265. doi:10.1089/neu.2019.6749
   PubMed Web of Science ®Google Scholar
• Yuan J, Zou M, Xiang X, et al. Curcumin improves neural function after spinal cord injury by the joint inhibition of the intracellular and extracellular components of glial scar. J Surg Res. 2015;195:235–245. doi:10.1016/j.jss.2014.12.055
   PubMed Web of Science ®Google Scholar
• Gao F, Shen J, Zhao L, et al. Curcumin alleviates lipopolysaccharide (LPS)-activated neuroinflammation via modulation of miR-199b-5p/IkB kinase β (IKKb)/nuclear factor kappa B (NF-κB) pathway in microglia. Med Sci Monit. 2019;25:9801–9810. doi:10.12659/MSM.918237
   PubMed Web of Science ®Google Scholar
• Barboza JN, Filho C, Silva RO, et al. An overview on the anti-inflammatory potential and antioxidant profile of eugenol. Oxid Med Cell Longev. 2018;2018:3957262. doi:10.1155/2018/3957262
   PubMed Web of Science ®Google Scholar
• Ma L, Mu Y, Zhang Z, et al. Eugenol promotes functional recovery and alleviates inflammation, oxidative stress, and neural apoptosis in a rat model of spinal cord injury. Restor Neurol Neurosci. 2018;36:659–668.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao J, Peng M, et al. A review on central nervous system effects of gastrodin. Front Pharmacol. 2018;9:24. doi:10.3389/fphar.2018.00024
   PubMed Web of Science ®Google Scholar
• Du F, Wang X, Shang B, et al. Gastrodin ameliorates spinal cord injury via antioxidant and anti-inflammatory effects. Acta Biochim Pol. 2016;63:589–593. doi:10.18388/abp.2016_1272
   PubMed Web of Science ®Google Scholar
• Hu J-Z, Wang X-K, Cao Y, et al. Potentiation of spinal cord conduction and neuroprotection following nanodelivery of DL-3-n-butylphthalide in titanium implanted nanomaterial in a focal spinal cord injury induced functional outcome, blood-spinal cord barrier breakdown and edema formation. Int Rev Neurobiol. 2019;146:153–188. doi:10.1016/bs.irn.2019.06.009
   PubMed Web of Science ®Google Scholar
• Zheng B, Zhou Y, Zhang H, et al. Dl-3-n-butylphthalide prevents the disruption of blood-spinal cord barrier via inhibiting endoplasmic reticulum stress following spinal cord injury. Int J Biol Sci. 2017;13:1520–1531. doi:10.7150/ijbs.21107
   PubMed Web of Science ®Google Scholar
• Ye Z-Y, Xing H-Y, Wang B, et al. DL-3-n-butylphthalide protects the blood-brain barrier against ischemia/hypoxia injury via upregulation of tight junction proteins. Chin Med J. 2019;132:1344–1353. doi:10.1097/CM9.0000000000000232
   PubMed Web of Science ®Google Scholar
• He Z, Zhou Y, Lin L, et al. Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4/NF-κB signalling. J Cell Mol Med. 2017;21:3010–3022. doi:10.1111/jcmm.13212
   PubMed Web of Science ®Google Scholar
• Sowndhararajan K, Deepa P, Kim M, et al. Neuroprotective and cognitive enhancement potentials of baicalin: a review. Brain Sci. 2018;8:104. doi:10.3390/brainsci8060104
   PubMed Web of Science ®Google Scholar
• Cao Y, Lia G, Wang Y-F, et al. Neuroprotective effect of baicalin on compression spinal cord injury in rats. Brain Res. 2010;1357:115–123. doi:10.1016/j.brainres.2010.07.108
   PubMed Web of Science ®Google Scholar
• Tu X-K, Yang W-Z, Liang R-S, et al. Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem Res. 2011;36:2022–2028. doi:10.1007/s11064-011-0526-y
   PubMed Web of Science ®Google Scholar
• Zhu H, Wang Z, Xing Y, et al. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. J Ethnopharmacol. 2012;141:714–720. doi:10.1016/j.jep.2011.08.063
   PubMed Web of Science ®Google Scholar
• Kang S, Liu S, Li H, et al. Baicalin effects on rats with spinal cord injury by anti-inflammatory and regulating the serum metabolic disorder. J Cell Biochem. 2018;119:7767–7779. doi:10.1002/jcb.27136
   PubMed Web of Science ®Google Scholar
• Li L, Hou X, Xu R, et al. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol. 2017;31:17–36. doi:10.1111/fcp.12232
   PubMed Web of Science ®Google Scholar
• Lin J, Pan X, Huang C, et al. Dual regulation of microglia and neurons by Astragaloside IV‐mediated mTORC1 suppression promotes functional recovery after acute spinal cord injury. J Cell Mol Med. 2020;24:671–685. doi:10.1111/jcmm.14776
   PubMed Web of Science ®Google Scholar
• Zhang D, Wang Q, Wang S, et al. Astragoloside IV loaded polycaprolactone membrane repairs blood spinal cord barrier and recovers spinal cord function in traumatic spinal cord injury. J Biomed Nanotechnol. 2019;15:799–812. doi:10.1166/jbn.2019.2715
   PubMed Web of Science ®Google Scholar
• Dai W-L, Zhang L, Han L, et al. Regulation of the K ATP-JNK gap junction signaling pathway by immunomodulator astragaloside IV attenuates neuropathic pain. Reg Anesth Pain Med. 2020;45:955–963. doi:10.1136/rapm-2020-101411
   PubMed Web of Science ®Google Scholar
• Pollier J, Goossens A. Oleanolic acid. Phytochemistry. 2012;77:10–15. doi:10.1016/j.phytochem.2011.12.022
   PubMed Web of Science ®Google Scholar
• Martín R, Carvalho-Tavares J, Hernández M, et al. Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role. Biochem Pharmacol. 2010;79:198–208. doi:10.1016/j.bcp.2009.08.002
   PubMed Web of Science ®Google Scholar
• Wang J-L, Ren C-H, Feng J, et al. Oleanolic acid inhibits mouse spinal cord injury through suppressing inflammation and apoptosis via the blockage of p38 and JNK MAPKs. Biomed Pharmacother. 2020;123:109752. doi:10.1016/j.biopha.2019.109752
   PubMed Web of Science ®Google Scholar
• Chen D, Huang C, Chen Z. A review for the pharmacological effect of lycopene in central nervous system disorders. Biomed Pharmacother. 2019;111:791–801. doi:10.1016/j.biopha.2018.12.151
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang J, Gu Z, et al. Effect of lycopene on the blood-spinal cord barrier after spinal cord injury in mice. Biosci Trends. 2016;10:288–293. doi:10.5582/bst.2016.01062
   PubMed Web of Science ®Google Scholar
• Hua Y, Xu N, Ma T, et al. Anti-inflammatory effect of lycopene on experimental spinal cord ischemia injury via cyclooxygenase-2 suppression. Neuroimmunomodulation. 2019;26:84–92. doi:10.1159/000495466
   PubMed Web of Science ®Google Scholar
• Budzynska B, Faggio C, Kruk-Slomka M, et al. Rutin as neuroprotective agent: from bench to bedside. Curr Med Chem. 2019;26:5152–5164. doi:10.2174/0929867324666171003114154
   PubMed Web of Science ®Google Scholar
• Zhang P, Ma X. Effect of rutin on spinal cord injury through inhibition of the expression of MIP-2 and activation of MMP-9, and downregulation of Akt phosphorylation. Mol Med Rep. 2015;12:7554–7560. doi:10.3892/mmr.2015.4357
   PubMed Web of Science ®Google Scholar
• Wu J, Maoqiang L, Fan H, et al. Rutin attenuates neuroinflammation in spinal cord injury rats. J Surg Res. 2016;203:331–337. doi:10.1016/j.jss.2016.02.041
   PubMed Web of Science ®Google Scholar
• Çiftçi U, Delen E, Vural M, et al. Efficiacy of resveratrol and quercetin after experimental spinal cord injury. Ulus Travma Acil Cerrahi Derg. 2016;22:423–431. doi:10.5505/tjtes.2016.44575
   PubMed Web of Science ®Google Scholar
• Schültke E, Griebel RW, Juurlink BHJ. Quercetin attenuates inflammatory processes after spinal cord injury in an animal model. Spinal Cord. 2010;48:857–861. doi:10.1038/sc.2010.45
   PubMed Web of Science ®Google Scholar
• Wang Y, Li W, Wang M, et al. Quercetin reduces neural tissue damage and promotes astrocyte activation after spinal cord injury in rats. J Cell Biochem. 2018;119:2298–2306. doi:10.1002/jcb.26392
   PubMed Web of Science ®Google Scholar
• Fan H, Tang H-B, Shan L-Q, et al. Quercetin prevents necroptosis of oligodendrocytes by inhibiting macrophages/microglia polarization to M1 phenotype after spinal cord injury in rats. J Neuroinflammation. 2019;16:206. doi:10.1186/s12974-019-1613-2
   PubMed Web of Science ®Google Scholar
• Jiang W, Huang Y, Han N, et al. Quercetin suppresses NLRP3 inflammasome activation and attenuates histopathology in a rat model of spinal cord injury. Spinal Cord. 2016;54:592–596. doi:10.1038/sc.2015.227
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu Y, Zhao Z, et al. Effects of green tea polyphenols on caveolin-1 of microvessel fragments in rats with cerebral ischemia. Neurol Res. 2010;32:963–970. doi:10.1179/016164110X12700393823570
   PubMed Web of Science ®Google Scholar
• Liu X, Wang Z, Wang P, et al. Green tea polyphenols alleviate early BBB damage during experimental focal cerebral ischemia through regulating tight junctions and PKCalpha signaling. BMC Complement Altern Med. 2013;13:187. doi:10.1186/1472-6882-13-187
   PubMed Web of Science ®Google Scholar
• Yu D-S, Liu L-B, Cao Y, et al. Combining bone marrow stromal cells with green tea polyphenols attenuates the blood-spinal cord barrier permeability in rats with compression spinal cord injury. J Mol Neurosci. 2015;56:388–396. doi:10.1007/s12031-015-0564-z
   PubMed Web of Science ®Google Scholar
• Lee JY, Choi HY, Baik HH, et al. Cordycepin-enriched WIB-801C from Cordyceps militaris improves functional recovery by attenuating blood-spinal cord barrier disruption after spinal cord injury. J Ethnopharmacol. 2017;203:90–100. doi:10.1016/j.jep.2017.03.047
   PubMed Web of Science ®Google Scholar
• Kang O-H, Lee G-H, Choi HJ, et al. Ethyl acetate extract from Angelica Dahuricae Radix inhibits lipopolysaccharide-induced production of nitric oxide, prostaglandin E2 and tumor necrosis factor-alpha via mitogen-activated protein kinases and nuclear factor-kappaB in macrophages. Pharmacol Res. 2007;55:263–270. doi:10.1016/j.phrs.2006.12.001
   PubMed Web of Science ®Google Scholar
• Moon YJ, Lee JY, Oh MS, et al. Inhibition of inflammation and oxidative stress by Angelica dahuricae radix extract decreases apoptotic cell death and improves functional recovery after spinal cord injury. J Neurosci Res. 2012;90:243–256. doi:10.1002/jnr.22734
   PubMed Web of Science ®Google Scholar
• Tian X, Liang T, Liu Y, et al. Extraction, structural characterization, and biological functions of Lycium Barbarum Polysaccharides: a review. Biomolecules. 2019;9:389. doi:10.3390/biom9090389
   PubMed Web of Science ®Google Scholar
• Zhang Y-K, Wang J, Liu L, et al. The effect of Lycium barbarum on spinal cord injury, particularly its relationship with M1 and M2 macrophage in rats. BMC Complement Altern Med. 2013;13:67. doi:10.1186/1472-6882-13-67
   PubMed Web of Science ®Google Scholar
• Gillessen A, Schmidt HH-J. Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther. 2020;37:1279–1301. doi:10.1007/s12325-020-01251-y
   PubMed Web of Science ®Google Scholar
• Tsai M-J, Liao J-F, Lin D-Y, et al. Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation. Neurochem Int. 2010;57:867–875. doi:10.1016/j.neuint.2010.09.005
   PubMed Web of Science ®Google Scholar
• Yune TY, Lee JY, Cui CM, et al. Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats. J Neurochem. 2009;110:1276–1287. doi:10.1111/j.1471-4159.2009.06214.x
   PubMed Web of Science ®Google Scholar
• Tu T-H, Liou D-Y, Lin D-Y, et al. Characterizing the neuroprotective effects of S/B remedy (Scutellaria baicalensis Georgi and Bupleurum scorzonerifolfium Willd) in spinal cord injury. Molecules. 2019;24:1885. doi:10.3390/molecules24101885
   PubMed Web of Science ®Google Scholar